Related Experiment Videos
Obstetric antiphospholipid syndrome: current uncertainties should guide our way
D W Branch1, R M Silver, T F Porter
1University of Utah Health Sciences Center and Intermountain Healthcare, Salt Lake City, Utah, USA. ware.branch@hsc.utah.edu
Lupus
|April 1, 2010
Summary
Obstetric antiphospholipid syndrome (APS) diagnosis and treatment require further study. Current practices often treat women with recurrent miscarriage based on unclear criteria, highlighting a need for improved understanding and standardized care for antiphospholipid antibodies (aPL).
Area of Science:
- Reproductive medicine
- Immunology
- Obstetrics
Background:
- Obstetric Antiphospholipid Syndrome (APS) is well-recognized globally.
- Clinical practice in the US shows an increase in diagnoses not meeting established criteria.
- Confusion exists regarding APS diagnosis and criteria among clinicians and patients.
Purpose of the Study:
- To address uncertainties in obstetric Antiphospholipid Syndrome (APS).
- To advocate for further clinical study to improve understanding and patient care.
- To clarify diagnostic and treatment ambiguities in reproductive medicine.
Main Methods:
- Review of current clinical practices in obstetric APS.
- Analysis of diagnostic criteria adherence.
- Discussion of 'empiric treatment' trends.
Main Results:
- Increased diagnosis of 'APS' in women not meeting Sapporo criteria.
- Common use of heparin for recurrent miscarriage with low or indeterminate antiphospholipid antibody (aPL) levels.
- Prevalence of 'empiric treatment' driven by both clinicians and patients.
Conclusions:
- Further clinical research is essential for obstetric APS.
- Clarification of diagnostic and laboratory criteria is needed.
- Standardized approaches to aPL testing and treatment are crucial for improved patient outcomes.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...